BlackRock
ASXC

BlackRock’s Asensus Surgical, Inc. ASXC Stock Holding History

BlackRock’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,467,621
Closed -$1.15M – 5367
2024
Q2 		$1.15M Buy
3,467,621
+3
+0% +$1 ﹤0.01% 4139
2024
Q1 		$798K Buy
3,467,618
+477
+0% +$139 ﹤0.01% 4258
2023
Q4 		$1.11M Hold
3,467,141
– – ﹤0.01% 4224
2023
Q3 		$936K Sell
3,467,141
-232,846
-6% -$84.6K ﹤0.01% 4265
2023
Q2 		$1.87M Buy
3,699,987
+44,503
+1% +$26.6K ﹤0.01% 4077
2023
Q1 		$2.41M Sell
3,655,484
-3,625
-0.1% -$2.46K ﹤0.01% 3965
2022
Q4 		$1.27M Sell
3,659,109
-4,625
-0.1% -$1.88K ﹤0.01% 4332
2022
Q3 		$1.65M Sell
3,663,734
-20,584
-0.6% -$10.7K ﹤0.01% 4286
2022
Q2 		$1.47M Sell
3,684,318
-11,749,109
-76% -$5.24M ﹤0.01% 4381
2022
Q1 		$9.67M Sell
15,433,427
-360,564
-2% -$278K ﹤0.01% 3593
2021
Q4 		$17.5M Buy
15,793,991
+73,666
+0.5% +$114K ﹤0.01% 3354
2021
Q3 		$29.1M Buy
15,720,325
+13,274
+0.1% +$29.8K ﹤0.01% 3039
2021
Q2 		$49.8M Buy
15,707,051
+13,197,435
+526% +$33M ﹤0.01% 2706
2021
Q1 		$8.16M Buy
2,509,616
+1,905,705
+316% +$6.9M ﹤0.01% 3691
2020
Q4 		$377K Sell
603,911
-287,842
-32% -$132K ﹤0.01% 4388
2020
Q3 		$310K Buy
891,753
+610,529
+217% +$236K ﹤0.01% 4338
2020
Q2 		$152K Sell
281,224
-906,835
-76% -$438K ﹤0.01% 4420
2020
Q1 		$418K Buy
1,188,059
+180,753
+18% +$189K ﹤0.01% 4090
2019
Q4 		$1.48M Buy
1,007,306
+13,953
+1% +$48.5K ﹤0.01% 3880
2019
Q3 		$8M Sell
993,353
-36,067
-4% -$490K ﹤0.01% 3312
2019
Q2 		$18.2M Buy
1,029,420
+7,348
+0.7% +$161K ﹤0.01% 2893
2019
Q1 		$31.6M Sell
1,022,072
-33,490
-3% -$1.12M ﹤0.01% 2535
2018
Q4 		$31M Buy
1,055,562
+88,197
+9% +$4.01M ﹤0.01% 2497
2018
Q3 		$72.9M Buy
967,365
+208,091
+27% +$14.1M ﹤0.01% 2172
2018
Q2 		$43M Buy
759,274
+625,575
+468% +$22.8M ﹤0.01% 2447
2018
Q1 		$2.96M Sell
133,699
-1,706
-1% -$39K ﹤0.01% 3575
2017
Q4 		$3.4M Buy
135,405
+82,779
+157% +$2.55M ﹤0.01% 3549
2017
Q3 		$979K Buy
52,626
+11,500
+28% +$134K ﹤0.01% 3916
2017
Q2 		$380K Sell
41,126
-245,219
-86% -$2.33M ﹤0.01% 4092
2017
Q1 		$4.5M Buy
286,345
+285,403
+30,298% +$4.95M ﹤0.01% 3408
2016
Q4 		$16K Sell
942
-38
-4% -$779 ﹤0.01% 3306
2016
Q3 		$21K Buy
980
+182
+23% +$3.33K ﹤0.01% 3275
2016
Q2 		$13K Buy
798
+608
+320% +$19.1K ﹤0.01% 3366
2016
Q1 		$10K Buy
190
+134
+239% +$5.74K ﹤0.01% 3169
2015
Q4 		$2K Sell
56
-15,582
-100% -$502K ﹤0.01% 3337
2015
Q3 		$460K Buy
15,638
+15,582
+27,825% +$578K ﹤0.01% 1524
2015
Q2 		$2K Hold
56
– – ﹤0.01% 3211
2015
Q1 		$2K Buy
+56
New +$2.11K ﹤0.01% 3133

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BlackRock's ASXC Position: Q3 2024 in Review

BlackRock sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 3,467,621 shares — an estimated $1.15M sold.

BlackRock first reported a position in ASXC in Q1 2015 and held it in 38 quarters. The position peaked at $72.9M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • BlackRock reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • BlackRock sold 3,467,621 Asensus Surgical, Inc. shares in Q3 2024, an estimated $1.15M.
  • BlackRock first reported a position in Asensus Surgical, Inc. in Q1 2015 and held it in 38 quarters.
  • BlackRock's Asensus Surgical, Inc. position peaked at $72.9M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.